- Home
- TNDM vs INMD Comparison
TNDM vs INMD Comparison
Compare TNDM & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNDM
- INMD
- Stock Information
- Founded
- TNDM 2006
- INMD 2008
- Country
- TNDM United States
- INMD Israel
- Employees
- TNDM N/A
- INMD N/A
- Industry
- TNDM Medical/Dental Instruments
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TNDM Health Care
- INMD Health Care
- Exchange
- TNDM Nasdaq
- INMD Nasdaq
- Market Cap
- TNDM 1.1B
- INMD 1.3B
- IPO Year
- TNDM 2013
- INMD 2019
- Fundamental
- Price
- TNDM $22.98
- INMD $14.45
- Analyst Decision
- TNDM Buy
- INMD Hold
- Analyst Count
- TNDM 15
- INMD 6
- Target Price
- TNDM $39.80
- INMD $17.56
- AVG Volume (30 Days)
- TNDM 1.6M
- INMD 1.5M
- Earning Date
- TNDM 04-30-2025
- INMD 04-28-2025
- Dividend Yield
- TNDM N/A
- INMD N/A
- EPS Growth
- TNDM N/A
- INMD 8.69
- EPS
- TNDM N/A
- INMD 2.29
- Revenue
- TNDM $982,951,000.00
- INMD $392,408,000.00
- Revenue This Year
- TNDM $8.49
- INMD $1.63
- Revenue Next Year
- TNDM $10.78
- INMD $5.17
- P/E Ratio
- TNDM N/A
- INMD $6.32
- Revenue Growth
- TNDM 27.65
- INMD N/A
- 52 Week Low
- TNDM $15.75
- INMD $13.68
- 52 Week High
- TNDM $53.69
- INMD $19.85
- Technical
- Relative Strength Index (RSI)
- TNDM 69.81
- INMD 41.46
- Support Level
- TNDM $16.34
- INMD $14.01
- Resistance Level
- TNDM $18.22
- INMD $15.12
- Average True Range (ATR)
- TNDM 1.13
- INMD 0.61
- MACD
- TNDM 0.80
- INMD 0.05
- Stochastic Oscillator
- TNDM 92.55
- INMD 24.62
About TNDM Tandem Diabetes Care Inc.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.